THE Therapeutic Goods Administration (TGA) has issued a Safety Advisory warning involving Morphine Sulfate Injection BP 30mg in 1mL ampoule.
The TGA highlights that this product is not safe to be used for either the epidural or intrathecal routes.
Morphine Sulfate Injection BP 30 mg in 1 mL ampoule is an unregistered product (sourced from overseas) that has been approved for use as an alternative product during the current shortage of DBL Morphine Sulfate 30 mg/1 mL injection BP ampoule.
DBL Morphine Sulfate 30 mg/1 mL injection BP ampoule is the only registered morphine 30 mg injection product marketed in Australia and is not expected to be available again until 30 May 2019.
In the meantime, the TGA has granted approval to Link Medical Products to supply for the relief of severe pain not responsive to non-opioid analgesics.
For more see tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Mar 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Mar 19
